Sarah Breen is an accomplished professional with extensive experience in analytical research and development within the biopharmaceutical industry. Currently serving as a Director at Merck since January 2019, Sarah has held various roles at the company, including Scientist in the Late Stage Analytics group. Prior to rejoining Merck, Sarah worked as an Operations Lead and Scientist at Bristol-Myers Squibb, focusing on the development and qualification of advanced analytical methods for biologics and protein therapeutics. Sarah's early career included positions as a Bioprocess Development Intern and a Forensic Laboratory Intern, as well as laboratory analyst experience at Benchmark EnviroAnalytical, Inc. Sarah holds a Master of Business and Science in Drug Discovery & Development from Rutgers University, a BS in Biochemistry from Montclair State University, and a BS in Biology from the University of South Florida.
This person is not in any teams
This person is not in any offices